Skip to main content
Erschienen in: Obesity Surgery 9/2019

09.07.2019 | Review Article

Randomized Controlled Trial of One Anastomosis Gastric Bypass Versus Roux-En-Y Gastric Bypass for Obesity: Comparison of the YOMEGA and Taiwan Studies

verfasst von: Wei-Jei Lee, Owaid M. Almalki, Kong-Han Ser, Jung-Chien Chen, Yi-Chih Lee

Erschienen in: Obesity Surgery | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The YOMEGA study (Y-study) was a randomized trial comparing one anastomosis gastric bypass (OAGB) and Roux-en-Y gastric bypass (RYGB). Here, we aim to compare the Y-study and our pioneer trial from Taiwan (T-study).

Methods

Data from the Y-study and the T-study were collected and compared.

Results

The Y-study recruited 234 patients with a mean body mass index (BMI) of 43.9 and age of 43.5 years. The T-study recruited 80 patients with a similar mean BMI of 44.3 and mean age of 31.4 years. The studies had similar findings including (1) OAGB is easier and possibly safer procedure than RYGB. Both studies showed that OAGB had a shorter operation time than RYGB, but a lower surgical complication rate was only demonstrated in T-study. (2) Both procedures have similar weight loss but OAGB features better glycemic control than RYGB. Weight loss at 2 years after surgery was similar between two procedures, but OAGB reduced HbA1c to a greater degree than RYGB at 2 years in Y-study (− 2.3% vs. − 1.3%; p = 0.025). The resolution of the metabolic syndrome was 100% for both groups in the T-study. (3) OAGB carried a higher risk of malnutrition. OAGB had more malabsorptive problems with a lower hemoglobin level than RYGB at 2 years after surgery. Adverse malnutrition events occurred in nine (7.8%) OAGB patients in the Y-study. Four (3.4%) patients of OAGB received revision surgery in Y-study but none in T-study. (4) Bile reflux was noted in OAGB patients but did not influence quality of life or revision rate. Y-study found that bile in the gastric pouch was present in 16% of patients in the OAGB group versus none in the RYGB, but no inter-group difference in quality of life was detected. There was a trend for RYGB patients to experience more abdominal pain than OAGB.

Conclusions

Both studies showed that OAGB is a technically easier procedure and features better glycemic control than RYGB, but has a mal-absorptive effect. However, the bile reflux and abdominal pain controversies persisted.
Literatur
1.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef
2.
Zurück zum Zitat Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.PubMedCrossRef Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.PubMedCrossRef
3.
Zurück zum Zitat Lee WJ, Huang MT, Wang W, et al. Bariatric surgery: Asia-pacific perspective. Obes Surg. 2005;15:751–7.PubMedCrossRef Lee WJ, Huang MT, Wang W, et al. Bariatric surgery: Asia-pacific perspective. Obes Surg. 2005;15:751–7.PubMedCrossRef
4.
5.
Zurück zum Zitat Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009;19(12):1605–11.PubMedCrossRef Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2008. Obes Surg. 2009;19(12):1605–11.PubMedCrossRef
6.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32.PubMedCrossRef Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32.PubMedCrossRef
7.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoliminal procedure: IFSO worldwide survey 2014. Obes Surg. 2017;27:2279–89.PubMedPubMedCentralCrossRef Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoliminal procedure: IFSO worldwide survey 2014. Obes Surg. 2017;27:2279–89.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276–80.PubMedCrossRef Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11(3):276–80.PubMedCrossRef
9.
10.
Zurück zum Zitat Noun R, Skaff J, Riachi E, et al. One thousand consecutive mini- gastric bypass: short- and long-term outcome. Obes Surg. 2012;22:697–703.PubMedCrossRef Noun R, Skaff J, Riachi E, et al. One thousand consecutive mini- gastric bypass: short- and long-term outcome. Obes Surg. 2012;22:697–703.PubMedCrossRef
11.
Zurück zum Zitat Bruzzi M, Rau C, Voron T, et al. Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis. 2015;11:321–6.PubMedCrossRef Bruzzi M, Rau C, Voron T, et al. Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis. 2015;11:321–6.PubMedCrossRef
12.
Zurück zum Zitat Lee WJ, Lin YH. Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence. Obes Surg. 2014;24:1749–56.CrossRefPubMed Lee WJ, Lin YH. Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence. Obes Surg. 2014;24:1749–56.CrossRefPubMed
13.
Zurück zum Zitat Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus roux-en-Y gastric bypass for obesity (YOMEGA): a multicenter, randomized, open-label, non-inferiority trial. Lancet. 2019;393:1299–309.CrossRefPubMed Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus roux-en-Y gastric bypass for obesity (YOMEGA): a multicenter, randomized, open-label, non-inferiority trial. Lancet. 2019;393:1299–309.CrossRefPubMed
14.
Zurück zum Zitat Mahawar KK. Findings of YOMEGA trial need to be interpreted with caution (led to edit). Obes Surg. 2019; April 23 on line Mahawar KK. Findings of YOMEGA trial need to be interpreted with caution (led to edit). Obes Surg. 2019; April 23 on line
15.
Zurück zum Zitat Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on metabolic syndrome. Arch Surg. 2004;139(10):1088–92.CrossRefPubMed Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on metabolic syndrome. Arch Surg. 2004;139(10):1088–92.CrossRefPubMed
16.
Zurück zum Zitat Wang FG, Yan WM, Yan M, et al. Outcomes of mini-vs roux-en-Y gastric bypass: a meta-analysis and systematic review. Int J Surg. 2018;56:7–14.PubMedCrossRef Wang FG, Yan WM, Yan M, et al. Outcomes of mini-vs roux-en-Y gastric bypass: a meta-analysis and systematic review. Int J Surg. 2018;56:7–14.PubMedCrossRef
17.
Zurück zum Zitat Quan Y, Huang A, Ye M, et al. Efficacy of laparoscopic mini gastric bypass for obesity and type 2 diabetes mellitus: a systematic review and meta-analysis. Gastroenterol Res Pract. 2015;2015:152852. 13 pagesPubMedPubMedCentralCrossRef Quan Y, Huang A, Ye M, et al. Efficacy of laparoscopic mini gastric bypass for obesity and type 2 diabetes mellitus: a systematic review and meta-analysis. Gastroenterol Res Pract. 2015;2015:152852. 13 pagesPubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Bhandari M, Nautiyal HK, Kosta S, et al. Comparison of one anastomosis gastric bypass (OAGB) and roux-en-Y gastric bypass (RYGB) for treatment of obesity: a five-year study. Surg Obes Relat Dis. 2019; May 25 on line first Bhandari M, Nautiyal HK, Kosta S, et al. Comparison of one anastomosis gastric bypass (OAGB) and roux-en-Y gastric bypass (RYGB) for treatment of obesity: a five-year study. Surg Obes Relat Dis. 2019; May 25 on line first
19.
Zurück zum Zitat Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, roux-en-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32.CrossRefPubMed Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, roux-en-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32.CrossRefPubMed
20.
Zurück zum Zitat Ruiz-Tovar J, Carbajo MA, Jimenez JM, et al. Long-term follow-up after sleeve gastrectomy versus roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of co-morbidities. Surg Endos. 2019;33(2):401–10.CrossRef Ruiz-Tovar J, Carbajo MA, Jimenez JM, et al. Long-term follow-up after sleeve gastrectomy versus roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of co-morbidities. Surg Endos. 2019;33(2):401–10.CrossRef
21.
Zurück zum Zitat Stenberg E, Szabo E, Agren G, et al. Closure of mesenteric defects in laparoscopic gastric bypass: a multicenter, randomized, parallel, open-label trial. Lancet. 2016;387(10026):1397–404.PubMedCrossRef Stenberg E, Szabo E, Agren G, et al. Closure of mesenteric defects in laparoscopic gastric bypass: a multicenter, randomized, parallel, open-label trial. Lancet. 2016;387(10026):1397–404.PubMedCrossRef
22.
Zurück zum Zitat Chowbey P, Baijal M, Kantharia NS, et al. Mesenteric defect closure decreases the incidence of internal hernia following laparoscopic roux-en-Y gastric bypass: a retrospective cohort study. Obes Surg. 2016;26(9):2029–34.PubMedCrossRef Chowbey P, Baijal M, Kantharia NS, et al. Mesenteric defect closure decreases the incidence of internal hernia following laparoscopic roux-en-Y gastric bypass: a retrospective cohort study. Obes Surg. 2016;26(9):2029–34.PubMedCrossRef
23.
Zurück zum Zitat Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543–51.PubMedCrossRef Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543–51.PubMedCrossRef
24.
Zurück zum Zitat Nguyen NT, Paya M, Stevens M, et al. The relationship between hospital volume and outcome in bariatric surgery at academic medical center. Ann Surg. 2004;240:586–94.PubMedPubMedCentral Nguyen NT, Paya M, Stevens M, et al. The relationship between hospital volume and outcome in bariatric surgery at academic medical center. Ann Surg. 2004;240:586–94.PubMedPubMedCentral
25.
Zurück zum Zitat Buchwald H, Estok R, Fahrback K, et al. Trends in mortality in bariatric surgery a systematic review and meta analysis. Surgery. 2007;142:621–32.PubMedCrossRef Buchwald H, Estok R, Fahrback K, et al. Trends in mortality in bariatric surgery a systematic review and meta analysis. Surgery. 2007;142:621–32.PubMedCrossRef
26.
Zurück zum Zitat The longitudinal assessment of bariatric surgery consortium. Peri-operative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54.CrossRef The longitudinal assessment of bariatric surgery consortium. Peri-operative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54.CrossRef
27.
Zurück zum Zitat Almalki O, Lee WJ, Chong K, et al. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of roux-en-Y versus single anastomosis gastric bypass. Surg Obes Relat Dis. 2018;14(4):509–16.PubMedCrossRef Almalki O, Lee WJ, Chong K, et al. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of roux-en-Y versus single anastomosis gastric bypass. Surg Obes Relat Dis. 2018;14(4):509–16.PubMedCrossRef
28.
Zurück zum Zitat Homan J, Boerboom A, Aarts E, et al. A longer biliopancreatic limb in roux-en-Y gastric bypass improves weight loss in the first year after surgery: results of a randomized controlled trial. Obes Surg. 2018;28(12):3744–55.PubMedCrossRef Homan J, Boerboom A, Aarts E, et al. A longer biliopancreatic limb in roux-en-Y gastric bypass improves weight loss in the first year after surgery: results of a randomized controlled trial. Obes Surg. 2018;28(12):3744–55.PubMedCrossRef
29.
Zurück zum Zitat Murad Jr AJ, Cohen RV, de Godoy EP, et al. A prospective single-arm trial of modified long biliopancreatic and short alimentary limbs roux-en-Y gastric bypass in type 2 diabetes patients with morbid obesity. Obes Surg. 2018;28(3):599–605.PubMedCrossRef Murad Jr AJ, Cohen RV, de Godoy EP, et al. A prospective single-arm trial of modified long biliopancreatic and short alimentary limbs roux-en-Y gastric bypass in type 2 diabetes patients with morbid obesity. Obes Surg. 2018;28(3):599–605.PubMedCrossRef
30.
Zurück zum Zitat Boerboom A, Homan J, Arts E, et al. A long biliopancreatic and short alimentary limb results in more weight loss in revisional RYGB surgery. Outcomes of the randomized controlled ELEGANCE REDO trial. Surg Obes Relat Dis. 2019;15(1):60–72.PubMedCrossRef Boerboom A, Homan J, Arts E, et al. A long biliopancreatic and short alimentary limb results in more weight loss in revisional RYGB surgery. Outcomes of the randomized controlled ELEGANCE REDO trial. Surg Obes Relat Dis. 2019;15(1):60–72.PubMedCrossRef
31.
Zurück zum Zitat Miyachi T, Nagao M, Shikashi S, et al. Biliopancreatic limb plays an important role in metabolic improvement after duodenal-jejunal bypass in a rat model of diabetes. Surgery. 2016;159(5):1360–71.PubMedCrossRef Miyachi T, Nagao M, Shikashi S, et al. Biliopancreatic limb plays an important role in metabolic improvement after duodenal-jejunal bypass in a rat model of diabetes. Surgery. 2016;159(5):1360–71.PubMedCrossRef
32.
Zurück zum Zitat Molinaro A, Wahlstrom A, Marschall HU. Role of bile acids in metabolic control. Trends Endocrinol Metab. 2018;29(1):31–41.PubMedCrossRef Molinaro A, Wahlstrom A, Marschall HU. Role of bile acids in metabolic control. Trends Endocrinol Metab. 2018;29(1):31–41.PubMedCrossRef
33.
Zurück zum Zitat Ise I, Tanaka N, Imoto H, et al. Changes in enterohepatic circulation after duodenal-jejunal bypass and reabsorption of bile acids in the bilio-pancreatic limb. Obes Surg. 2019 (Febuary 25 on-line first;29:1901–10.PubMedCrossRef Ise I, Tanaka N, Imoto H, et al. Changes in enterohepatic circulation after duodenal-jejunal bypass and reabsorption of bile acids in the bilio-pancreatic limb. Obes Surg. 2019 (Febuary 25 on-line first;29:1901–10.PubMedCrossRef
34.
Zurück zum Zitat Mika A, Kaska L, Proczko-Stepaniak M, et al. Evidence that the length of bile loop determines serum bile acid concentration and glycemic control after bariatric surgery. Obes Surg. 2018;28(11):3405–14.PubMedCrossRef Mika A, Kaska L, Proczko-Stepaniak M, et al. Evidence that the length of bile loop determines serum bile acid concentration and glycemic control after bariatric surgery. Obes Surg. 2018;28(11):3405–14.PubMedCrossRef
35.
Zurück zum Zitat Zorrilla-Nunez LF, Campbell A, Giambartolomei G, et al. The importance of the biliopancreatic limb length in gastric bypass: a systematic review. Surg Obes Relat Dis. 2019;15(1):43–50.PubMedCrossRef Zorrilla-Nunez LF, Campbell A, Giambartolomei G, et al. The importance of the biliopancreatic limb length in gastric bypass: a systematic review. Surg Obes Relat Dis. 2019;15(1):43–50.PubMedCrossRef
36.
Zurück zum Zitat Mingrone G, Panunz S, De Gaetamo A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-center, randomized controlled trials. Lancet. 2015;386:964–73.PubMedCrossRef Mingrone G, Panunz S, De Gaetamo A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-center, randomized controlled trials. Lancet. 2015;386:964–73.PubMedCrossRef
37.
Zurück zum Zitat Sethi M, Chau E, Youn A, et al. Long-term outcomes after biliopancreatic diversion with and without duodenal switch:2-, 5-, 10-year data. Surg Obes Relat Dis. 2016;12(9):1697–705.PubMedCrossRef Sethi M, Chau E, Youn A, et al. Long-term outcomes after biliopancreatic diversion with and without duodenal switch:2-, 5-, 10-year data. Surg Obes Relat Dis. 2016;12(9):1697–705.PubMedCrossRef
38.
Zurück zum Zitat Lee W, Wang W, Lee YC, et al. Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight. Obes Surg. 2008;18:294–9.CrossRefPubMed Lee W, Wang W, Lee YC, et al. Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight. Obes Surg. 2008;18:294–9.CrossRefPubMed
39.
Zurück zum Zitat Chen JC, Shen CY, Lee WJ, et al. Protein deficiency after gastric bypass: the role of common limb length in revision surgery. Surg Obes Relat Dis. 2019;15(3):441–6.PubMedCrossRef Chen JC, Shen CY, Lee WJ, et al. Protein deficiency after gastric bypass: the role of common limb length in revision surgery. Surg Obes Relat Dis. 2019;15(3):441–6.PubMedCrossRef
40.
Zurück zum Zitat Chen CY, Lee WJ, Lee HM, et al. Laparoscopic conversion of gastric bypass complication to sleeve gastrectomy: technique and early results. Obes Surg. 2016;26:2014–21.PubMedCrossRef Chen CY, Lee WJ, Lee HM, et al. Laparoscopic conversion of gastric bypass complication to sleeve gastrectomy: technique and early results. Obes Surg. 2016;26:2014–21.PubMedCrossRef
41.
Zurück zum Zitat Lee WJ, Lee YC, Ser KH, et al. Revisional surgery for laparoscopic minigastric bypass. Surg Obes Relat Dis. 2011;7(4):486–91.PubMedCrossRef Lee WJ, Lee YC, Ser KH, et al. Revisional surgery for laparoscopic minigastric bypass. Surg Obes Relat Dis. 2011;7(4):486–91.PubMedCrossRef
42.
Zurück zum Zitat Lee WJ, Ser KH, Lee YC, et al. Laparoscopic roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.PubMedCrossRef Lee WJ, Ser KH, Lee YC, et al. Laparoscopic roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.PubMedCrossRef
43.
Zurück zum Zitat Alkhalifah N, Lee WJ, Tan CH, et al. 15-year experience of laparoscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures. Surg Endosc. 2018;32(6):3024–31.PubMedCrossRef Alkhalifah N, Lee WJ, Tan CH, et al. 15-year experience of laparoscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures. Surg Endosc. 2018;32(6):3024–31.PubMedCrossRef
44.
Zurück zum Zitat Gormsen J, Burcharth J, Gogenur I, et al. Prevalence and risk factors for chronic abdominal pain after roux-en-Y gastric bypass surgery: a cohort study. Ann Surg. 2019; April 1 on line first Gormsen J, Burcharth J, Gogenur I, et al. Prevalence and risk factors for chronic abdominal pain after roux-en-Y gastric bypass surgery: a cohort study. Ann Surg. 2019; April 1 on line first
45.
Zurück zum Zitat Higa K, Ho T, Tercero F, et al. Laparoscopic roux-en-Y gastric bypass: 10-year follow-up. Surg Obes Relat Dis. 2011;7(4):516–25.PubMedCrossRef Higa K, Ho T, Tercero F, et al. Laparoscopic roux-en-Y gastric bypass: 10-year follow-up. Surg Obes Relat Dis. 2011;7(4):516–25.PubMedCrossRef
46.
Zurück zum Zitat Angrisani L, Cutolo PP, Formisano G, et al. Laparoscopic adjustable gastric banding versus roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial. Surg Obes Relat Dis. 2013;9(3):405–16.PubMedCrossRef Angrisani L, Cutolo PP, Formisano G, et al. Laparoscopic adjustable gastric banding versus roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial. Surg Obes Relat Dis. 2013;9(3):405–16.PubMedCrossRef
47.
Zurück zum Zitat Edholm D, Sevensson F, Naslund I, et al. Long-term results 11 years after primary gastric bypass in 384 patients. Surg Obes Relat Dis. 2013;9(5):708–13.CrossRefPubMed Edholm D, Sevensson F, Naslund I, et al. Long-term results 11 years after primary gastric bypass in 384 patients. Surg Obes Relat Dis. 2013;9(5):708–13.CrossRefPubMed
48.
Zurück zum Zitat Obeid NR, Malick W, Concors SJ, et al. Long-term outcomes after roux-en-Y gastric bypass:10- to 13-year data. Surg Obes Relat Dis. 2016;12(1):11–22.PubMedCrossRef Obeid NR, Malick W, Concors SJ, et al. Long-term outcomes after roux-en-Y gastric bypass:10- to 13-year data. Surg Obes Relat Dis. 2016;12(1):11–22.PubMedCrossRef
49.
Zurück zum Zitat Mehaffey JH, Turrentine FE, Miller MS, et al. Roux-en-Y gastric bypass 10-year follow-up: the found poupulation. Surg Obes Relat Dis. 2016;12(4):778–83.CrossRef Mehaffey JH, Turrentine FE, Miller MS, et al. Roux-en-Y gastric bypass 10-year follow-up: the found poupulation. Surg Obes Relat Dis. 2016;12(4):778–83.CrossRef
Metadaten
Titel
Randomized Controlled Trial of One Anastomosis Gastric Bypass Versus Roux-En-Y Gastric Bypass for Obesity: Comparison of the YOMEGA and Taiwan Studies
verfasst von
Wei-Jei Lee
Owaid M. Almalki
Kong-Han Ser
Jung-Chien Chen
Yi-Chih Lee
Publikationsdatum
09.07.2019
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 9/2019
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04065-2

Weitere Artikel der Ausgabe 9/2019

Obesity Surgery 9/2019 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.